Medical experts discuss the evolving treatment landscape and adverse events associated with 3L colorectal cancer treatment.
Funding supported by Taiho Oncology. Content independently developed by OncLive.
EP. 6: Patient Case 2: A 62-Year-Old Woman with Metastatic Rectal Cancer
April 11th 2024John Strickler, MD, presents the case of a 62-year-old woman with rectal cancer, and Arvind N. Dasari, MD, MS, provides clinical insights on his approach to third-line treatment with regorafenib, highlighting dose strategy and patient education.